EP0975610A4 - PHARMACEUTICAL COMPOUNDS BASED ON TRIPEPTIDES AND TETRAPEPTIDES - Google Patents
PHARMACEUTICAL COMPOUNDS BASED ON TRIPEPTIDES AND TETRAPEPTIDESInfo
- Publication number
- EP0975610A4 EP0975610A4 EP98907625A EP98907625A EP0975610A4 EP 0975610 A4 EP0975610 A4 EP 0975610A4 EP 98907625 A EP98907625 A EP 98907625A EP 98907625 A EP98907625 A EP 98907625A EP 0975610 A4 EP0975610 A4 EP 0975610A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tetrapeptides
- tripeptides
- pharmaceutical compounds
- compounds based
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3911597P | 1997-02-26 | 1997-02-26 | |
| US39115P | 1997-02-26 | ||
| PCT/US1998/003666 WO1998038178A1 (en) | 1997-02-26 | 1998-02-25 | Tripeptide and tetrapeptide pharmaceutical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0975610A1 EP0975610A1 (en) | 2000-02-02 |
| EP0975610A4 true EP0975610A4 (en) | 2000-05-17 |
Family
ID=21903772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98907625A Withdrawn EP0975610A4 (en) | 1997-02-26 | 1998-02-25 | PHARMACEUTICAL COMPOUNDS BASED ON TRIPEPTIDES AND TETRAPEPTIDES |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0975610A4 (en) |
| JP (1) | JP2001513775A (en) |
| AU (1) | AU6338698A (en) |
| CA (1) | CA2281107A1 (en) |
| WO (1) | WO1998038178A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001500484A (en) * | 1996-08-30 | 2001-01-16 | イーライ・リリー・アンド・カンパニー | Method for producing pharmaceutical compounds |
| EP1229934B1 (en) | 1999-10-01 | 2014-03-05 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040184A1 (en) * | 1995-03-07 | 1996-12-19 | University Of Hawaii | New cryptophycins from synthesis |
| WO1997007798A1 (en) * | 1995-08-30 | 1997-03-06 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1997023211A1 (en) * | 1995-12-22 | 1997-07-03 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1998008505A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1998008506A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254682A (en) * | 1989-12-08 | 1993-10-19 | Merck & Co., Inc. | Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs |
| US5194605A (en) * | 1989-12-08 | 1993-03-16 | Merck & Co., Inc. | Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| US5225528A (en) * | 1990-02-27 | 1993-07-06 | Merck & Co., Inc. | Cyclic hexapeptide oxytocin antagonists |
-
1998
- 1998-02-25 AU AU63386/98A patent/AU6338698A/en not_active Abandoned
- 1998-02-25 EP EP98907625A patent/EP0975610A4/en not_active Withdrawn
- 1998-02-25 CA CA002281107A patent/CA2281107A1/en not_active Abandoned
- 1998-02-25 WO PCT/US1998/003666 patent/WO1998038178A1/en not_active Ceased
- 1998-02-25 JP JP53780298A patent/JP2001513775A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040184A1 (en) * | 1995-03-07 | 1996-12-19 | University Of Hawaii | New cryptophycins from synthesis |
| WO1997007798A1 (en) * | 1995-08-30 | 1997-03-06 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1997023211A1 (en) * | 1995-12-22 | 1997-07-03 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1998008505A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
| WO1998008506A1 (en) * | 1996-08-30 | 1998-03-05 | Eli Lilly And Company | Pharmaceutical compounds |
Non-Patent Citations (2)
| Title |
|---|
| KOISO, YUKIKO ET AL: "Effects of arenastatin A and its synthetic analogs on microtubule assembly", CHEM.-BIOL. INTERACT. (1996), 102(3), 183-191, 1996, XP000872569 * |
| See also references of WO9838178A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2281107A1 (en) | 1998-09-03 |
| AU6338698A (en) | 1998-09-18 |
| JP2001513775A (en) | 2001-09-04 |
| WO1998038178A1 (en) | 1998-09-03 |
| EP0975610A1 (en) | 2000-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300952I2 (en) | Peramivir and pharmaceutically acceptable salts thereof | |
| EE04440B1 (en) | Capareceptor opioid peptides and a pharmaceutical composition | |
| BR9607317A (en) | Peptides and pharmaceutical composition | |
| BR9607318A (en) | Peptides and pharmaceutical composition | |
| DE69926351D1 (en) | A STATIN AND ASPIRIN-CONTAINING MEDICAMENT | |
| DE69618587D1 (en) | CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS | |
| NO20001776L (en) | drugs | |
| PT881906E (en) | PHARMACEUTICAL COMPOSITION FOR IMMUNOMODELACTION BASED ON PEPTIDE AND ADJUVANTES | |
| ZA985618B (en) | Sulfonamide compounds and pharmaceutical use thereof | |
| DE69620930D1 (en) | Plate and pen | |
| EE04294B1 (en) | A pharmaceutical composition for combining piperidinoalkanol decongestant | |
| MA24580A1 (en) | DIPEPTIDE COMPOUNDS | |
| ATE367150T1 (en) | DRUG | |
| ID24654A (en) | OMEPRAZOLA PHARMACEUTICAL FORMULATION | |
| DE69616084D1 (en) | BAG SEALER AND DISPENSER | |
| NO980546D0 (en) | Pharmaceutical agents | |
| NO981008D0 (en) | Pharmaceutical formulation | |
| PT906301E (en) | BENZOFURYL DERIVATIVES AND THEIR USE | |
| EP0850057A4 (en) | PHARMACEUTICAL COMPOUNDS | |
| PT955810E (en) | SOLID MIXTURES BASED ON SULFONYLURIES AND ADJUVANTS | |
| EE04001B1 (en) | A peptide pharmaceutical composition | |
| FR2742053B1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON MEQUITAZINE | |
| PT1037652E (en) | PHARMACEUTICAL COMPOSITIONS BASED ON DALPHRISTIN AND QUINUPRISTINE AND THEIR PREPARATION | |
| EE9800275A (en) | Prolonged-release pharmaceutical preparations containing misolastin | |
| PT949923E (en) | STABILIZED PHARMACEUTICAL COMPOSITIONS BASED ON QUINUPRISTINE AND DALPHRISTIN AND THEIR PREPARATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990819 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL PAYMENT 19990810;LT PAYMENT 19990819;LV PAYMENT 19990819;RO PAYMENT 19990819;SI PAYMENT 19990819 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07D 273/00 A, 7C 07D 413/06 B, 7A 61K 31/395 B |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20000330 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20011115 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20020326 |